Table 2.
Characteristics of the test treatment (final analysis set).
| Characteristic | |
|---|---|
| Presence of aura in the test treatment, % (n/N) | 31.9 (29/91) |
| Baseline pain severity in the test treatment, % (n/N) | |
| Mild | 20.9 (19/91) |
| Moderate | 59.3 (54/91) |
| Severe | 19.8 (18/91) |
| Presence of baseline associated symptoms in the test treatment, % (n/N) | |
| Nausea or vomiting | 45.1 (41/91) |
| Photophobia | 81.3 (74/91) |
| Phonophobia | 71.4 (65/91) |
| Baseline functional disability, % (n/N) | |
| No limitation | 43.8 (32/73) |
| Some limitation | 41.1 (30/73) |
| Moderate limitation | 15.1 (11/73) |
| Severe limitation | 0 (0/73) |
| Time from headache onset, % (n/N), min | |
| 0–30 | 73 (66/91) |
| 30–60 | 22 (20/91) |
| 60 or more | 5 (5/91) |
The number of observations analyzed vary by parameter because of missing values.